Physician Assistant in Fort Meade, MD Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Mr. David Allen Zeller Jr., MPAS PA-C, APA, CCHP Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2480 Llewellyn Ave Ste 5800, Fort Meade, MD 20755 Phone: 253-677-7655

Edwin Lockwood Leavitt, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2257 Huber Road, Fort Meade, MD 20755 Phone: 443-845-6295    Fax: 301-677-7149

Mr. Carlos Ernesto Posada, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2480 Llewellyn Ave, Fort Meade, MD 20755 Phone: 301-677-8145    Fax: 301-677-8176

Suzanne C Sinnott, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2480 Llewellyn Ave, Fort Meade, MD 20755 Phone: 301-677-8796    Fax: 301-677-8491

Mr. John Christopher Hubbard, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 2480 Llewellyn Ave, Fort Meade, MD 20755 Phone: 301-677-8874

Alyson Rhodes, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 2480 Llewellyn Ave, Fort Meade, MD 20755 Phone: 301-677-8897

News Archive

UC emergency medicine assistant professor compares efficacy of two seizure medications to prevent SE

When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity. In a paper published in the June Academic Emergency Medicine, UC emergency medicine assistant professor Jason McMullan, MD, found that the best means of stopping status epilepticus may be with the least direct medication.

Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany

Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it has initiated the Phase III trial of DCVax-L in Germany.

Febuxostat recommended by panel for treatment of hyperuricemia in patients with gout

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.

Rothman researchers to develop gold standard definition for periprosthetic joint infection

A rise in periprosthetic joint infection (PJI) rates has the orthopedic community moving to develop it's first-ever agreed upon definition and diagnostic criteria to help better treat patients.

Radiation associated with increased risk of adverse cardiac events in lung cancer patients

As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure.

Read more Medical News

› Verified 8 days ago